Matthew Meyerson
Researcher Next ID · RN-019635
Researcher · Biochemistry, Genetics and Molecular Biology
Cambridge, United States
- Works count
- 1,761
- Citation count
- 279,606
- H-index
- 211
- i10-index
- 450
Research interests
Publications
Discovering the anticancer potential of non-oncology drugs by systematic viability profiling
Nature Cancer · 2020 · https://doi.org/10.1038/s43018-019-0018-6
Mutational signature in colorectal cancer caused by genotoxic pks+ E. coli
Nature · 2020 · https://doi.org/10.1038/s41586-020-2080-8
Commensal Microbiota Promote Lung Cancer Development via γδ T Cells
Cell · 2019 · https://doi.org/10.1016/j.cell.2018.12.040
Oncogenic Signaling Pathways in The Cancer Genome Atlas
Cell · 2018 · https://doi.org/10.1016/j.cell.2018.03.035
Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes
Nature Medicine · 2018 · https://doi.org/10.1038/s41591-018-0016-8
Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer
Science · 2017 · 10.1126/science.aal5240
Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer
Cell · 2017 · 10.1016/j.cell.2017.09.007
Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma
Cell · 2017 · 10.1016/j.cell.2017.05.046
Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma
Cancer Cell · 2017 · 10.1016/j.ccell.2017.07.007
Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma
Cancer Cell · 2016 · 10.1016/j.ccell.2016.04.002
Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma
Cancer Cell · 2016 · 10.1016/j.ccell.2016.04.002
Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas
Nature Genetics · 2016 · 10.1038/ng.3564
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
Cell · 2016 · 10.1016/j.cell.2015.12.028
Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
Cell · 2015 · 10.1016/j.cell.2015.03.053
Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets
Cancer Discovery · 2015 · 10.1158/2159-8290.cd-15-0369
Comprehensive molecular characterization of urothelial bladder carcinoma
Nature · 2014 · 10.1038/nature12965
Comprehensive molecular characterization of gastric adenocarcinoma
Nature · 2014 · 10.1038/nature13480
The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma
Cancer Cell · 2014 · 10.1016/j.ccr.2014.07.014
Discovery and saturation analysis of cancer genes across 21 tumour types
Nature · 2014 · 10.1038/nature12912
The genetic landscape of high-risk neuroblastoma
Nature Genetics · 2013 · 10.1038/ng.2529
Signatures of mutational processes in human cancer
Nature · 2013 · https://doi.org/10.1038/nature12477
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Nature · 2013 · 10.1038/nature12213
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
Cell Host & Microbe · 2013 · 10.1016/j.chom.2013.07.007
Pan-cancer patterns of somatic copy number alteration
Nature Genetics · 2013 · 10.1038/ng.2760
Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia
Cell · 2013 · 10.1016/j.cell.2013.01.019
Punctuated Evolution of Prostate Cancer Genomes
Cell · 2013 · 10.1016/j.cell.2013.03.021
Absolute quantification of somatic DNA alterations in human cancer
Nature Biotechnology · 2012 · 10.1038/nbt.2203
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Nature · 2012 · https://doi.org/10.1038/nature11003
Prognostically relevant gene signatures of high-grade serous ovarian carcinoma
Journal of Clinical Investigation · 2012 · 10.1172/jci65833
A Landscape of Driver Mutations in Melanoma
Cell · 2012 · 10.1016/j.cell.2012.06.024
Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations
Nature · 2012 · 10.1038/nature11329
Dissecting the genomic complexity underlying medulloblastoma
Nature · 2012 · 10.1038/nature11284
Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing
Cell · 2012 · 10.1016/j.cell.2012.08.029
Genomic analysis identifies association of Fusobacterium with colorectal carcinoma
Genome Research · 2011 · 10.1101/gr.126573.111
The Mutational Landscape of Head and Neck Squamous Cell Carcinoma
Science · 2011 · 10.1126/science.1208130
Initial genome sequencing and analysis of multiple myeloma
Nature · 2011 · 10.1038/nature09837
The genomic complexity of primary human prostate cancer
Nature · 2011 · 10.1038/nature09744
Integrated genomic analyses of ovarian carcinoma
Nature · 2011 · https://doi.org/10.1038/nature10166
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Cancer Cell · 2010 · 10.1016/j.ccr.2009.12.020
The landscape of somatic copy-number alteration across human cancers
Nature · 2010 · 10.1038/nature08822
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
Nature · 2009 · 10.1038/nature08460
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas
Nature Genetics · 2009 · 10.1038/ng.465
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
Nature · 2008 · https://doi.org/10.1038/nature07385
Somatic mutations affect key pathways in lung adenocarcinoma
Nature · 2008 · 10.1038/nature07423
High-throughput oncogene mutation profiling in human cancer
Nature Genetics · 2007 · 10.1038/ng1975
Characterizing the cancer genome in lung adenocarcinoma
Nature · 2007 · 10.1038/nature06358
Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma
Proceedings of the National Academy of Sciences · 2007 · 10.1073/pnas.0710052104
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
Cancer Cell · 2005 · 10.1016/j.ccr.2005.03.023
EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib
New England Journal of Medicine · 2005 · 10.1056/nejmoa044238
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Science · 2004 · https://doi.org/10.1126/science.1099314
Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses
Proceedings of the National Academy of Sciences · 2001 · 10.1073/pnas.191502998
Current projects
No projects listed.